ZLAB Zai Lab Ltd

NEUTRAL Impact: 4/10 8-K
Horizon weeks Filed May 21, 2026 Processed 19d 10h ago SEC 0001628280-26-037387
8-K context-dependent: Items 5.02
Latest settled — T+5d
ZLAB ▼ -8.17% at T+5d
NEUTRAL call ✗ call lost -8.17% · α vs SPY -9.83% · entry $18.61 → $17.09
Next anchor: T+20d in 12d
Last close $16.48 (close Jun 8) · -11.45% from $18.61 entry
Entry anchored
May 21, 2026
via day open
T+1d
-0.86%
call -0.86% · α -1.45%
$18.45
settled 19d ago
T+5d
-8.17%
call -8.17% · α -9.83%
$17.09
settled 12d ago
T+20d
call — · α —
in 12d
T+60d
call — · α —
in 2mo

Price Chart

Loading chart...

Executive Summary

Zai Lab's President and COO Josh Smiley is departing effective immediately, with his last day on May 22, 2026. Responsibilities are being absorbed by CEO Samantha Du and the existing management team, with no named replacement. While a single C-suite departure is notable, the company has a strong analyst consensus (79% bullish) and the CEO/founder is directly stepping in, mitigating disruption risk.

Actionable Insight

Monitor for any further management departures or strategic shifts in the next quarter. The lack of a named successor and immediate absorption of duties by the CEO suggests a potential restructuring or cost-saving move, but at current levels this is a routine organizational change for a $2.1B biopharma.

Key Facts

  • President and COO Josh Smiley ceases role effective May 18, 2026, last day May 22, 2026
  • No replacement named; CEO Samantha Du and management team assume responsibilities
  • Severance provided per existing employment agreement subject to customary release
  • Filed on Form 8-K with only Item 5.02 (officer departure)

Financial Impact

No financial figures disclosed in the filing

Risk Factors

  • If additional key executives depart, it may signal broader organizational instability
  • No clear succession plan may create temporary operational gaps

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
79% bullish (14 analysts)

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001628280-26-037387
Document: 0001628280-26-037387-index-headers.html0001628280-26-037387
Document: 0001628280-26-037387-index.html0001628280-26-037387
Document: 0001628280-26-037387.txt0001628280-26-037387
13 reports for ZLAB
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for ZLAB — sortable, filterable
Type Now
May 21, 2026
19d ago
8-K
NEUTRAL ★ 4/10
$18.61 $17.09▼ −8.17%▼ −9.83%$16.48 (−11.45%)
May 19, 2026
21d ago
Insider Cluster
NEUTRAL ★ 3/10
$18.81 $18.69▼ −0.64%▼ −1.88%$16.48 (−12.39%)
May 19, 2026
21d ago
Insider Cluster
BEARISH ★ 6/10
$18.81 $18.69▲ +0.64%▲ +1.88%$16.48 (+12.39%)
May 7, 2026
4w ago
8-K
BEARISH ★ 6/10
$19.77 $20.47▼ −3.57%▼ −2.06%$16.48 (+16.62%)
Apr 28, 2026
6w ago
DEFA14A
NEUTRAL ★ 2/10
$22.14 $20.98▼ −5.24%▼ −6.93%$16.48 (−25.56%)
Apr 6, 2026
9w ago
144
NEUTRAL ★ 3/10
$20.50 $21.34▲ +4.10%▼ −0.04%$16.48 (−19.61%)
Apr 6, 2026
9w ago
144
NEUTRAL ★ 3/10
$20.50 $21.34▲ +4.10%▼ −0.04%$16.48 (−19.61%)
Mar 11, 2026
13w ago
Insider Cluster
BEARISH ★ 5/10
$19.47 awaiting T+5awaiting T+5$16.48 (+15.34%)
Mar 5, 2026
13w ago
Insider Cluster
NEUTRAL ★ 4/10
$19.30 awaiting T+5awaiting T+5$16.48 (−14.61%)
Mar 3, 2026
14w ago
Insider Cluster
NEUTRAL ★ 3/10
$18.45 awaiting T+5awaiting T+5$16.48 (−10.68%)
Showing 10 of 13

US Market Status

Market Closed — Opens in 5h 36m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access